For the year ending April, the sports-fashion retailer said it expected adjusted profits of $699 million-$762 million, a lower range than previously forecast, citing recent tough business conditions and weak consumer confidence.
Related Posts
Pfizer Names New R&D Chief
Company veteran Chris Boshoff, who has led Pfizer’s cancer research and marketing for more than a year, will become chief scientific officer starting Jan. 1.
Experian Posts Revenue Growth in Line With Guidance
- staff
- January 15, 2025
- 0
The company reported total revenue growth of 8% at constant exchange rates for the third quarter of fiscal 2025, and confirmed its guidance for the […]
Novartis Raises Guidance as Key Drugs Boost Sales
Novartis now expects its core operating profit to grow in the mid to high teens, after second-quarter results outpaced analysts’ expectations, boosted by revenue from […]